http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011526684-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011526684-A |
| titleOfInvention | COPD diagnosis |
| abstract | The present invention relates to a method for diagnosing chronic obstructive pulmonary disease (COPD) in a human subject or the risk of a human subject developing COPD, which includes the following steps: -Providing a sample from a human subject; Determining the amount of caspase-cleaved cytokeratin-18 (ccCK-18), histones, heat shock protein 27 (HSP27), heat shock protein 70 (HSP70) and / or heat shock protein 90α (HSP90α) in the sample Step to do, The amount of ccCK-18, histone group, HSP27, HSP70 and / or HSP90α is increased compared to the amount of ccCK-18, histone group, HSP27, HSP70 and / or HSP90α in a healthy human subject. Diagnosing COPD, or-the amount of ccCK-18, histone group and / or HSP70 is reduced compared to the amount of ccCK-18, histone group and / or HSP70 in a healthy human subject If so, diagnosing the risk of developing COPD. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014509737-A |
| priorityDate | 2008-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 281.